Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) posted its quarterly earnings data on Tuesday. The company reported GBX (0.43) earnings per share for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 58.27% and a negative net margin of 40.51%.

Abingdon Health Stock Performance

Shares of ABDX opened at GBX 8 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.96 and a debt-to-equity ratio of 19.40. The firm’s fifty day simple moving average is GBX 6.60 and its two-hundred day simple moving average is GBX 6.47. Abingdon Health has a 12 month low of GBX 5.10 and a 12 month high of GBX 9. The stock has a market capitalization of £20.09 million, a P/E ratio of -8.60 and a beta of 0.25.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.